GHIT Fund Global Health Innovative Technology Fund

Featured News

June 1, 2018FILMS

Together we are better, together we are GHIT

March 29, 2018PRESS

As the GHIT Fund Closes Out First Five Years of R&D for Lifesaving Medical Br…

December 11, 2017TOOLS

Strategic Plan 2018-2022

Annual Report 2018

GHIT's 2018 Annual Report is now available. The report provides an overview of GHIT investments since its establishment, promising clinical candidates, access and delivery strategies, co-investment, and a financial summary of our activities in FY2018.

Press ReleaseArchive

March 28, 2019

GHIT Fund Announces Appointment of Catherine Ohura as New CEO and Executive D…
March 28, 2019

GHIT Fund Announces New Investments: A Total of 2.86 Billion Yen in Drug for …
December 13, 2018

GHIT Fund Announces New Investments in Vaccines for Dengue and Leishmaniasis,…

NewsArchive

August 1, 2019

New investment opportunity for Hit-to-Lead Platform
July 29, 2019

Japanese Foreign Minister’s Commendations for FY 2019 to Dr. Slingsby, …
July 26, 2019

TICAD VII dedicated website launched

EventsArchive

July 30, 2019 Upcoming

Upcoming Event: Partnering for Progress: Promoting Innovation & Access for Ne…
July 3, 2019 Upcoming

Save the Date: GHIT R&D Forum 2019 - Dec 6th
July 3, 2019 Past Event

Event Report: Uniting Efforts for Innovation, Access and Delivery: A Global D…

PublicationsArchive

June 3, 2019 GHIT Report

GHIT’s 2018 Annual Report Published
June 1, 2018 GHIT Report

GHIT’s 2017 Annual Report Published
May 27, 2018 GHIT Report

Strategic Plan 2018 Published

FilmsArchive

SILVAMP™ TB-LAM: Urine based TB diagnostics

Fosravuconazole for Mycetoma

Pediatric Praziquantel for Schistosomiasis

ToolsArchive

Strategic Plan 2018-2022

5th Anniversary Website

Advancing Portfolio